Even though OPN deficiency in NASH‐HCC mice induces stronger steatosis, steatohepatitis and fibrosis, it significantly protects against organ failure‐related death, which closely resembles human acute‐on‐chronic liver failure. This evidence concerns the gene SPP1 and metabolic dysfunction-associated steatohepatitis.